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ABSTRACT: Dihydrofolate reductase (DHFR) from Escher-
ichia coli (EcDHFR) adopts two major conformations, closed
and occluded, and movement between these two conforma-
tions is important for progression through the catalytic cycle.
DHFR from the cold-adapted organism Moritella profunda
(MpDHFR) on the other hand is unable to form the two
hydrogen bonds that stabilize the occluded conformation in
EcDHFR and so remains in a closed conformation during
catalysis. EcDHFR-S148P and MpDHFR-P150S were exam-
ined to explore the inﬂuence of the occluded conformation on
catalysis by DHFR. Destabilization of the occluded conformation did not aﬀect hydride transfer but altered the aﬃnity for the
oxidized form of nicotinamide adenine dinucleotide phosphate (NADP+) and changed the rate-determining step of the catalytic
cycle for EcDHFR-S148P. Even in the absence of an occluded conformation, MpDHFR follows a kinetic pathway similar to that
of EcDHFR with product release being the rate-limiting step in the steady state at pH 7, suggesting that MpDHFR uses a
diﬀerent strategy to modify its aﬃnity for NADP+. DHFRs from many organisms lack a hydrogen bond donor in the appropriate
position and hence most likely do not form an occluded conformation. The link between conformational cycling between closed
and occluded forms and progression through the catalytic cycle is speciﬁc to EcDHFR and not a general characteristic of
prokaryotic DHFR catalysis.
Dihydrofolate reductase (DHFR) catalyzes the reduction of7,8-dihydrofolate (DHF) to 5,6,7,8-tetrahydrofolate
(THF) in the presence of reduced nicotinamide adenine
dinucleotide phosphate (NADPH). DHFR is important for
maintaining the intracellular pool of THF, a cofactor involved in
many biological reactions that require transfer of a one-carbon
unit, such as biosynthesis of thymidylate, purines, and some
amino acids. Hence, DHFR is a major target for anticancer and
antibacterial drugs.1
During catalysis, DHFR from Escherichia coli (EcDHFR)
cycles through ﬁve intermediates, E·NADPH, E·NADPH·DHF,
E·NADP+·THF, E·THF, and E·NADPH·THF, with product
release from the mixed ternary complex E·NADPH·THF being
the rate-limiting step at pH ≤7 under steady state conditions
(Figure S1, Supporting Information).2 The M20 loop (residues
9−24) of EcDHFR switches between two conformations during
the catalytic cycle (Figure 1A). In reactant complexes E·NADPH
and E·NADPH·DHF, this loop adopts the “closed” conforma-
tion, packing against NADPH and preventing access of the
solvent to the active site. This conformation is stabilized by
hydrogen bonds between residues in the M20 loop and the FG
loop (residues 116−132), namely, Gly15(O) to Asp122(HN)
and Glu17(HN) to Asp122(Oδ2) (Figure 1B).2,3 In the product
binary and ternary complexes, on the other hand, the M20 loop
switches to the “occluded” conformation (Figure 1C). The two
hydrogen bonds between the M20 loop and FG loop that
stabilize the closed conformation are disrupted, and the occluded
conformation is instead stabilized by two hydrogen bonds
between Asn23 (O and HN) in the M20 loop and Ser148 (HN
and Oγ) in the GH loop (residues 142−149) (Figure 1C).2 The
nicotinamide group of the cofactor is blocked from entering the
active site by the M20 loop and protrudes into solution. It has
been proposed that movement between the closed and occluded
conformations is important for both modifying ligand aﬃnity
and aiding progression through the catalytic cycle.2,4
Previous work on DHFR from Moritella prof unda
(MpDHFR), a cold-adapted bacterium isolated from deep-sea
sediments,5 investigated the eﬀect of temperature and pressure
on the structure and thermodynamic stability as well as the steady
state and pre-steady state kinetics of the enzyme.6−10 Although
MpDHFR and EcDHFR have very similar crystal structures8 and
the two enzymes have 55% identical sequences,6 Ser148 of
EcDHFR is replaced with proline in MpDHFR, which therefore
cannot form either of the hydrogen bonds that stabilize the
occluded conformation. Indeed, the occluded conformation has
not been observed in other bacterial DHFRs, including
complexes of DHFRs from Lactobacillus casei (LcDHFR)11,12
and Bacillus anthracis (BaDHFR)13 that form the occluded
conformation in EcDHFR. BaDHFR has a proline residue at
position 148 (EcDHFR numbering), while in LcDHFR,11
Ser148 is replaced with alanine. Alanine can in principle form
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the backbone hydrogen bond with Asn23 but not the side chain
hydrogen bond (Figure S2, Supporting Information), although
EcDHFR-S148A is known to adopt the closed conformation in
the product complex rather than an occluded conformation.14
Despite its inability to form the occluded conformation,
LcDHFR is known to have a catalytic cycle very similar to that
of EcDHFR.15 In addition to MpDHFR, BaDHFR, and
LcDHFR, DHFRs from a number of other organisms have an
alternative residue in place of Ser148 (Figure S3, Supporting
Information). It is unlikely that these DHFRs are able to form the
occluded conformation, and it is therefore of interest to
investigate the importance of the occluded conformation in
DHFR catalysis.
To this end, EcDHFR-S148P and MpDHFR-P150S were
generated. Our results conﬁrm that the occluded conformation
assists the release of the oxidized cofactor NADP+ and
progression through the catalytic cycle but suggest that
alternative strategies are adopted by those bacterial DHFRs
incapable of forming this conformation.
■ MATERIALS AND METHODS
Chemicals. NADP+ and NADPH were purchased from
Melford. Folate was purchased from Sigma. Dihydrofolate was
prepared by dithionite reduction of folate.16 Tetrahydrofolate
was synthesized enzymatically from dihydrofolate using
EcDHFR17 in the presence of alcohol dehydrogenase from
Thermoanaerobacter brockii, 2-propanol, and NADP+ and
puriﬁed using a Dionex ICS3000 fast protein liquid chromato-
graph. 4-(R)-NADPD was prepared as described previously.18
All DHFRs were produced as reported previously9 and puriﬁed
by anion exchange chromatography on Q-Sepharose resin
followed by size exclusion chromatography on a Superdex 75
column. The concentrations of NADPH/NADPD, NADP+, and
MTX were determined spectrophotometrically using extinction
coeﬃcients of 6200 cm−1 M−1 at 339 nm,19 18700 cm−1 M−1 at
260 nm,20 and 22100 cm−1 M−1 at 302 nm,21 respectively. An
extinction coeﬃcient of 28000 cm−1 M−1 was used to determine
the concentrations of DHF and THF at 282 and 297 nm,
respectively.22,23
Site-Directed Mutagenesis. The Finnzymes Phusion site-
directed mutagenesis kit and the following primers were used to
generate MpDHFR-P150S and EcDHFR-S148P: MpDHFR-
P150S, 5′-GCGGCAGATGATAAAAACTCGCATAATTAC-
CGC-3′; and EcDHFR-S148P, 5′-GCTGATGCGCAGAACC-
CTCACAGCTATTGC-3′. Replaced bases are underlined.
Circular Dichroism Spectroscopy. An Applied Photo-
physics Chirascan spectrophotometer was used to measure
spectra between 195 and 400 nm using 10 μM protein in 5 mM
potassium phosphate (pH 7.0) in a quartz cuvette (0.1 cm path
length, Helma) under N2. Mean residue ellipticities ([Θ]MRE)
were calculated using the equation [Θ]MRE =Θ/(10ncl), whereΘ
is the measured ellipticity in millidegrees, n is the number of
backbone amide bonds, c is the concentration of protein in moles
per liter, and l is the path length in centimeters. Melting
temperatures were determined by plotting [Θ]MRE at 222 nm
against temperature.
Nuclear Magnetic Resonance (NMR) Experiments. All
NMR experiments were performed on a Bruker AVANCE III
600 MHz spectrometer with a QCI-P cryoprobe at 20 °C in 50
mM Tris-HCl buﬀer (pH 7.0) containing 1 mM NaCl and 10
mM β-mercaptoethanol. A 10-fold excess of ligands was used. An
equimolar solution of both ligands (NADP+ and folate or
NADP+ and THF) was prepared and adjusted to pH 7.0 before
addition to the DHFR; the pH was then checked before
measurement of the spectrum. D2O (5%) was added to all the
NMR samples before spectra were acquired. Spectra were
Figure 1. (A) Cartoon representation of EcDHFR (gray, PDB entry
1RX2)1 in the closed conformation. Important structural elements are
colored green. Positions of theM20, FG, and GH loops are shown in the
occluded conformation in EcDHFR (yellow, PDB entry 1RX6)2 and in
the closed conformation in MpDHFR (wheat, PDB entry 3IA4).8
Ligands are shown as sticks; folate is colored cyan and NADP+ pink. (B)
Alignment of the active site loops of EcDHFR (green, PDB entry
1DRE)2 and MpDHFR (wheat, PDB entry 3IA4)8 in complex with
methotrexate (MTX) and NADPH showing residues forming hydrogen
bonds that stabilize the closed and occluded conformations in EcDHFR,
and corresponding residues in MpDHFR. Hydrogen bonds stabilizing
the closed conformations are shown as dashed lines. (C) Alignment of
the active site loops of EcDHFR in the closed conformation (green,
PDB entry 1RX2)2 with ligands as described for panel A and in the
occluded conformation (yellow, PDB entry 1RX6)2 with 5,10-
dideazatetrahydrofolate (DDF) in pale pink and NADPH in yellow,
showing residues forming hydrogen bonds that stabilize the closed and
occluded conformations. Hydrogen bonds stabilizing the occluded
conformation are shown as dashed yellow lines.
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processed using NMRPipe24 and analyzed using CcpNmr
Analysis 2.2.2.25
Steady State Kinetic Measurements. Turnover rates were
measured spectrophotometrically on a JASCO V-660 spectro-
photometer by following the decrease in absorbance at 340 nm
during the reaction (ε340 = 11800 M
−1 cm−1).23 Initial rates were
determined under saturating conditions (100 μM NADPH and
DHF) at pH 7 in 100 mM potassium phosphate containing 100
mMNaCl and 10 mM β-mercaptoethanol and at pH 9 and 9.5 in
MTEN buﬀer (50 mMMES, 25 mMTris, 25 mM ethanolamine,
100 mM NaCl, and 10 mM β-mercaptoethanol). Temperature
dependence measurements were performed in phosphate buﬀer
because of the weak temperature dependence of its pKa
compared to that of organic amines. Product inhibition was
assessed at pH 5 and 7 in MTEN buﬀer by measuring the initial
rate with 100 nM enzyme, 100 μMNADPH, 100 μMDHF, and
NADP+ concentrations of 0.5 μM, 5 μM, 50 μM, 500 μM, 5 mM,
and 50 mM. The change in the initial rate with NADP+
concentration, normalized to the value without NADP+, was ﬁt
to a sigmoidal curve using SigmaPlot 10. Michaelis constants
were measured at pH 7 and 5 in MTEN buﬀer. To avoid
hysteresis,3 the enzyme (20−50 nM) was preincubated at the
desired temperature with NADPH (0.1−200 μM) for 1 min
prior to the addition of DHF (0.1−100 μM). When the
concentration of NADPH was varied, that of DHF was
maintained at 100 μM and vice versa. Each data point is the
result of three independent measurements. The change in the
initial rate with substrate concentration was ﬁt to the Michaelis−
Menten equation using SigmaPlot 10.
Pre-Steady State Kinetic Measurements. Hydride trans-
fer rate constants were measured under single-turnover
conditions on an Applied Photophysics stopped-ﬂow spectro-
photometer. The enzyme (ﬁnal concentration of 20 μM) was
preincubated with NADPH (ﬁnal concentration of 8 μM) for at
least 5 min in 100 mMpotassium phosphate (pH 7.0) containing
100 mM NaCl and 10 mM β-mercaptoethanol, and the reaction
was started by rapidly mixing with DHF (ﬁnal concentration of
200 μM) in the same buﬀer. The loss of ﬂuorescence resonance
energy transfer from the enzyme to NADPH during the reaction
was observed by exciting the sample at 292 nm and measuring
the emission using an output ﬁlter with a 400 nm cutoﬀ.
Dissociation Rate Constants. The rate constants of the
release of product from the diﬀerent binary and ternary
complexes were measured using the competition method
described previously.3,26,27 The E·THF, E·NADP+·THF, and
E·NADPH·THF complexes were mixed with a large excess of
MTX. The sample was excited at 292 nm, and the quenching of
the ﬂuorescence signal was monitored using a 305 nm cutoﬀ
ﬁlter.
Figure 2. 1H−15N HSQC spectra of the DHFR·NADP+·folate (black) and DHFR·NADP+·THF (red) complexes of (A) EcDHFR, (B) EcDHFR-
S148P, (C) MpDHFR, and (D) MpDHFR-P150S at 25 °C. Residues showing large amide chemical shift changes between the closed and occluded
conformations in EcDHFR are indicated (A). It can be seen that these residues do not display large chemical shift changes in EcDHFR-S148P or in
MpDHFR. Contours are set so that DHFR·NADP+·folate resonances appear open, to show areas of resonance overlap.
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■ RESULTS AND DISCUSSION
Structure and Thermal Stability. Circular dichroism
spectroscopy (Figures S4 and S5, Supporting Information) was
used to demonstrate that EcDHFR-S148P andMpDHFR-P150S
form folded proteins. The CD spectra were similar, but not
identical, to those of the wild-type enzymes, consistent with
some secondary structural diﬀerences in the apoenzyme
conformational ensembles. MpDHFR-P150S was found to
melt at 55.4± 0.2 °C, which is similar to the melting temperature
of wild-type EcDHFR (51.6 ± 0.7 °C)28 or wild-type MpDHFR
in the presence of methotrexate (53.7± 0.6 °C) but considerably
higher than that of MpDHFR (37.5 ± 0.8 °C).9 The melting
point of EcDHFR-S148P was 59.6± 0.2 °C, which is higher than
that of wild-type EcDHFR. This shows that while the S148P
mutation does not decrease the thermal stability of EcDHFR,
MpDHFR is more tolerant of high temperatures after Pro150 is
replaced with serine.
NMR spectroscopy was employed to investigate conforma-
tional changes following the chemical step of catalysis by the four
DHFRs (Figure 2). As observed previously, a large diﬀerence is
observed between the 1H−15N HSQC spectra of EcDHFR·
NADP+·folate and EcDHFR·NADP+·THF (Figure 2A). Diﬀer-
ences are seen throughout the enzyme but are largest in theM20,
FG, and GH loops, consistent with a change from the closed to
the occluded conformation.14,29 In contrast, no substantial
diﬀerence is observed between these two complexes for
EcDHFR-S148P (Figure 2B), as seen previously for EcDHFR-
S148A and EcDHFR-N23PP/S148A,14 neither of which is
capable of forming an occluded conformation. Similarly, no large
diﬀerence is observed between the 1H−15N HSQC spectra of
MpDHFR·NADP+·folate and MpDHFR·NADP+·THF (Figure
2C). This is consistent with our previous report of the NMR
assignment of the MpDHFR·NADP+·folate complex and
comparison with other complexes.30 Although some small
changes were observed for residues surrounding the folate
binding site and the cofactor pyrophosphate binding site, no
signiﬁcant changes were observed in the nicotinamide binding
pocket or for the residues of the M20 and FG loops. These
observations are consistent with there being no signiﬁcant
conformational change between the Michaelis complex and the
product complex in MpDHFR.
In MpDHFR-P150S, which should be capable of forming the
two hydrogen bonds necessary to stabilize the occluded
conformation, the DHFR·NADP+·THF complex gave lower-
quality spectra compared to those of the DHFR·NADP+·folate
complex, and clear diﬀerences between the HSQC spectra of the
two complexes were observed (Figure 2D). Several residues
show resonance doubling, with the same resonance present as in
the DHFR·NADP+·folate complex plus a new resonance with a
distinct chemical shift. As with the spectra for EcDHFR, the
changes were seen throughout the protein but are most notable
for G123 in the FG loop. The chemical shift perturbation for the
additional resonance of G123V in MpDHFR-P150S is very
similar to that of G121 in EcDHFR (Figure 2). We note that
spectra of the product complex were acquired before those of the
Michaelis complex mimic, and that both complexes were made
up from a single preparation of the enzyme. In addition, one-
dimensional 1H NMR spectroscopy indicated no signiﬁcant
degradation of THF during the acquisition of the HSQC
spectrum; the sample maintained its initial catalytic activity after
acquisition of the HSQC spectrum, and the large excess of
ligands coupled with the relative aﬃnities of the four enzymes for
NADP+ and THF (vide inf ra) makes incomplete binding of
either ligand unlikely. It is also unlikely that MpDHFR-P150S
becomes more dynamic on ligand binding, as it has been shown
that apo-EcDHFR and apo-MpDHFR give HSQC spectra
consistent with the presence of multiple conformations, whereas
both enzymes show well-resolved HSQCs consistent with a
single major conformation in a range of ligand com-
plexes.4,10,30,31 We are therefore conﬁdent that the lower quality
of the spectra of the product complex indicates the presence of
more than one species in solution rather than degradation,
unfolding, or other loss of sample integrity. It is therefore likely
that a proportion of MpDHFR-P150S is in an occluded-like
conformation, in slow exchange with the closed conformation.
It has been shown that a number of bacterial DHFRs, including
those with a proline residue at position 148 (EcDHFR
numbering), give diﬀerences between the HSQC spectra of the
DHFR·NADP+·folate and DHFR·NADP+·THF complexes
greater than what would be expected simply from the
replacement of folate.32 In one such case, DHFR from
Staphylococcus aureus (SaDHFR), a threonine residue is found
at position 148 (Figure S3, Supporting Information), which is in
principle capable of stabilizing an occluded conformation. At the
time of writing, the PDB contains no crystal structures of
SaDHFR in a complex expected to adopt the occluded
conformation. While such clear diﬀerences in the HSQC spectra
of the Michaelis and product complexes of these DHFRs32
indicate that the hydride transfer step is accompanied by a
conformational change, it is equally clear from our data that this
change is not universally a transition between closed and
occluded conformations.
Hydride Transfer. The pH dependence of the hydride
transfer rate constant was measured under single-turnover
conditions in MTEN buﬀer at 5 °C for MpDHFR and
MpDHFR-P150S and at 25 °C for EcDHFR18 and EcDHFR-
S148P (Figure S6, Supporting Information). The two mutants
were found to have similar pH dependencies with pKa values
around 6.5. The hydride transfer rate constants were similar to
those of their wild-type counterparts (Supporting Information).
The kinetic isotope eﬀect (KIE) on hydride transfer for
MpDHFR-P150S and EcDHFR-S148P was found to depend on
temperature in a fashion similar to that seen for MpDHFR and
EcDHFR (Figure 3 and Supporting Information), indicating that
altering either enzyme’s ability to form the occluded con-
formation does not aﬀect hydride transfer. Because both
EcDHFR-S148A and MpDHFR can form the closed con-
formation,8,14 this suggests that all DHFRs studied here are able
to form the closed conformation, from which hydride transfer
occurs, and further demonstrates that conformational changes
between the closed and occluded conformations do not aﬀect the
actual chemistry of the reaction.
Steady State Kinetics. The pH dependence of the steady
state rate constant kcat for the MpDHFR-catalyzed reaction is
bell-shaped with a maximum at pH ∼7 (Figure 4),9 while that of
EcDHFR is sigmoidal, as reported previously,33 with a maximum
at low pH (Figure 4). The decrease in kcat for MpDHFR at low
pH has been shown previously not to be due to protonation of
His24 (the only ionic residue close to the active site) or enzyme
inactivation.9
Interestingly, the pH dependence of kcat for MpDHFR-P150S
was found to be sigmoidal like that of EcDHFR, with a pH-
independent kcat of 14.5± 0.3 s
−1, very similar to the kcat for wild-
typeMpDHFR at pH 7 and 20 °C (15.6± 0.2 s−1)8 (Figure 4 and
Supporting Information). On the other hand, a 5-fold decrease in
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the value of kcat was observed for EcDHFR-S148P (2.1± 0.2 s
−1)
compared to that of wild-type EcDHFR (10.6 ± 1.5 s−1) at pH 6
and 20 °C. Similar to their wild-type counterparts,9,28 the two
variants have a KIE of unity at pH ≤7 under steady state
conditions (Supporting Information).
The Michaelis constants (KM) for NADPH and DHF were
measured for EcDHFR-S148P and MpDHFR-P150S at pH 7
and 5 at 20 °C (Table 1). Both variants have KM values similar to
those of their wild-type counterparts for both DHF and NADPH
at pH 7, although the KM for DHF with EcDHFR-S148P at pH 5
is 10 times higher than that of wild-type EcDHFR.
This type of bell-shaped steady state pH dependence has been
seen previously when residues in helix αC (Figure 1A and Figure
S3, Supporting Information) in EcDHFR were replaced by those
of helix αC of LcDHFR.34 A similar pH dependence was also
obtained when a Glu-Lys-Asn three-residue stretch (as found in
human DHFR) was inserted into the αC helix of EcDHFR.35
While these two EcDHFR αC mutants have approximately the
same kH and kcat as EcDHFR at pH 7, kcat is reduced by 50% at
lower pH,34,35 similar to the case for MpDHFR.9 In the case of
the Glu-Lys-Asn insertion, the decrease in kcat at low pH was
demonstrated to be due to impaired dissociation of THF from
the E·NADPH·THF complex,35 which is the rate-limiting step in
EcDHFR under steady state conditions.3 However, this is not the
case here, as the rate constant for dissociation of THF from
MpDHFR·NADPH·THF is not aﬀected by pH (vide inf ra).
Product Inhibition by NADP+.The occluded conformation
has been suggested to be important for avoiding product
inhibition in EcDHFR.2 It has been shown previously that
EcDHFR-N23PP/S148A and human DHFR, neither of which
can form the occluded conformation,14 are more susceptible to
product inhibition than wild-type EcDHFR.32 This was indeed
observed for EcDHFR-S148P, which gave an IC50 22-fold lower
than that observed for EcDHFR itself at pH 7 under our
experimental conditions (Table 2 and Figure S7, Supporting
Information). Similarly, MpDHFR is considerably more
susceptible to product inhibition than EcDHFR, although less
so than EcDHFR-S148P. MpDHFR-P150S is slightly less
susceptible to product inhibition than wild-type MpDHFR, but
more so than wild-type EcDHFR. This is consistent with its
apparent ability to form more than one conformation in the
product complex (vide supra), probably including an occluded-
like conformation. Interestingly, the IC50 values for the four
enzymes were all similar at pH 5, suggesting that the occluded
conformation exerts no inﬂuence onNADP+ aﬃnity under acidic
conditions.
Dissociation Rate Constants for THF. The dissociation
rate constants (koff) for THF from diﬀerent complexes (Table 3)
weremeasured at pH 5−7 and 25 °C forMpDHFR and pH 6 and
25 °C for the two variants, to explore the rate-limiting step.
Dissociation of THF from the MpDHFR·NADPH·THF mixed
ternary complex is essentially unaﬀected by pH over the range
measured (koff values of 19.2 ± 2.3 at pH 7, 19.1 ± 2.0 at pH 6,
and 15.7 ± 1.0 at pH 5). While the rate constant for this step is
similar to the kcat at pH 7, at higher pH hydride transfer becomes
rate-limiting9 and an alternative step must become rate-limiting
at low pH. This cannot be a diﬀerent product release step, as
dissociation of THF from the MpDHFR·THF and MpDHFR·
NADP+·THF complexes is slower than kcat, and so must
presumably be the release of the oxidized cofactor or the
subsequent rebinding of the reduced cofactor. The greater
aﬃnity of MpDHFR for DHF at low pH (at least as indicated by
Figure 3. Kinetic isotope eﬀect on hydride transfer at pH 7 by EcDHFR
(black), EcDHFR-S148P (red), MpDHFR (cyan), and MpDHFR-
P150S (orange), plotted on a logarithmic abscissa as a function of
inverse temperature.
Figure 4. pH dependence of kcat for MpDHFR
9 (cyan), MpDHFR-
P150S (orange), EcDHFR (black), and EcDHFR-S148P (red) in
MTEN buﬀer at 20 °C.
Table 1. KM Values for NADPH and DHF with EcDHFR,
EcDHFR-S148P, MpDHFR, and MpDHFR-P150S at 20 °C
enzyme pH KM
DHF (μM) KM
NADPH (μM)
EcDHFRa 7 0.7 ± 0.2 4.8 ± 1.0
5 0.7 ± 0.5 ndd
EcDHFR-S148P 7 0.7 ± 0.1 4.7 ± 0.7
5 6.8 ± 0.5 5.5 ± 0.4
MpDHFRb 7.5 2.4 ± 0.2 5.7 ± 0.2
5 0.4 ± 0.1c 10.8 ± 3.1
MpDHFR-P150S 7 2.2 ± 0.2 10.7 ± 0.6
5 3.2 ± 0.5 15.2 ± 0.9
aTaken from ref 3. bTaken from ref 9. cAt pH 5.5. dNot determined.
Table 2. IC50 Values (micromolar) for NADP
+ with EcDHFR,
EcDHFR-S148P, MpDHFR, and MpDHFR-P150S at 20 °C
enzyme pH 5 pH 7
EcDHFR 159 ± 8 820 ± 59
EcDHFR-S148P 189 ± 9 40 ± 1
MpDHFR 317 ± 50 170 ± 11
MpDHFR-P150S 263 ± 29 321 ± 12
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theKM values) suggests, but cannot conﬁrm, that DHF rebinding
is not rate-limiting. The substantial kinetic isotope eﬀect on
hydride transfer measured by stopped-ﬂow techniques10 also
supports this. An alternative possibility is that the catalytic cycle
in MpDHFR becomes branched at low pH, with two distinct
pathways contributing to the cycle, each with its own rate-
determining step. Branching of the catalytic cycle has been
suggested for other DHFRs,36−39 for which the occluded
conformation has not been observed and which lack the key
serine residue for stabilizing this conformation.
For MpDHFR-P150S, the rate constant of release of THF at
pH 6 from the E·NADPH·THF mixed ternary complex is also
similar to the kcat at pH 7. It is therefore likely that the kcat for this
variant is limited by dissociation of THF from the E·NADPH·
THF complex at all pH values below 7, as is the case for
EcDHFR.3 In contrast, for EcDHFR-S148P, kcat appears to be
limited by the dissociation of THF from the E·NADP+·THF
product ternary complex, not from the E·NADPH·THF mixed
ternary complex. This is diﬀerent from the case for EcDHFR-
N23PP/S148A; its NADP+ aﬃnity is suﬃciently high that
dissociation of this compound from the E·NADP+ binary
complex is the rate-limiting step.14 All THF koff values for
EcDHFR-S148P andMpDHFR-P150S are similar to those of the
wild-type enzymes, demonstrating that the mutations did not
aﬀect dissociation of THF.
Role of the Occluded Conformation. EcDHFR has often
been used as a paradigmatic model system to study the role of
protein motions for catalysis. Its catalytic cycle proceeds through
a series of ordered steps with the release of THF from the E·
NADPH·THF mixed ternary complex being rate-determining.3
Moreover, EcDHFR was shown to oscillate between closed and
occluded conformations,2 and this has been proposed to aid
progression through the catalytic cycle.4,40−42 In EcDHFR, the
closed to occluded conformational change must occur after the
hydride transfer step, while it has been shown that the occluded
to closed conformational change likely precedes the release of
product from the mixed ternary complex.43 This would indeed
place a strong control on progression through the catalytic cycle
and prevent product inhibition by reducing the aﬃnity for
NADP+ relative to NADPH.
Previous work investigating the role of the occluded
conformation has essentially focused on the eﬀect of changes
in the M20 loop. It has been shown that insertion of additional
residues toward the C-terminal end of theM20 loop in vertebrate
DHFRs compared to EcDHFR can account for the inability of
vertebrate DHFRs to form the occluded conformation.32
However, in MpDHFR, this region is highly similar to that of
EcDHFR. Both have the same number of residues, and the
diﬀerences, N23H and D27E substitutions (EcDHFR number-
ing), have been shown not to aﬀect catalysis strongly.9,44 Instead,
conformational diﬀerences between bacterial DHFRs are likely
to arise because of changes at position 148 (EcDHFR
numbering). Diﬀerences earlier in the M20 loop, M16L and
A19K substitutions, aﬀect kcat in EcDHFR but notMpDHFR and
do not aﬀect kH in either (DOI: 10.1021/bi500508z). As kcat
reports on the release of THF from the DHFR·NADP+·THF
mixed ternary complex and the corresponding occluded-to-
closed conformational change in EcDHFR, this provides further
evidence of the involvement of M20 loop motions in progression
through the catalytic cycle of EcDHFR but not that ofMpDHFR.
EcDHFR-S148P is unable to form the occluded conformation
and appears to bind NADP+ more tightly than EcDHFR (likely
slowing its release) without a signiﬁcant change in its koff for
THF. This leads to a change in the rate-limiting step to the
release of THF from the E·NADP+·THF product ternary
complex rather than from the E·NADPH·THF mixed ternary
complex as is seen in EcDHFR. The rate constant for hydride
transfer (kH) and the Michaelis constants (KM) remain
essentially unaﬀected. Recent work in our group has shown
that the chemistry in EcDHFR and MpDHFR is similar10 and
that conformational ﬂuctuations in EcDHFR do not drive the
chemical step of the reaction.45−47
MpDHFR similarly does not adopt the occluded conforma-
tion following the chemical step (vide supra), because of the
presence of proline in place of the key residue, Ser148 in
EcDHFR, that stabilizes this conformation. However, MpDHFR
likely follows a well-ordered catalytic cycle similar to that of
EcDHFR at pH 7. The release of product from the E·NADPH·
THF mixed ternary complex is rate-limiting as is seen in
EcDHFR, and the release of product from the E·NADP+·THF
complex clearly makes no signiﬁcant contribution to the catalytic
cycle despite the apparent elevated NADP+ aﬃnity compared to
that of EcDHFR (Table 3). Furthermore, MpDHFR-P150S does
show evidence supporting the formation of an occluded
conformation and most likely follows a catalytic cycle similar
to that of EcDHFR. The fact that this variant appears to have an
aﬃnity for NADP+ lower than that of MpDHFR further indicates
that the occluded conformation is important for NADP+ release.
The kcat for MpDHFR shows a bell-shaped dependence on pH,
instead of the sigmoidal curve observed for the EcDFHR
reaction. The descending limb at low pH is removed when the
occluded conformation is at least partially enabled in MpDHFR
catalysis via the P150S mutation, although the complementary
S148P mutation in EcDHFR does not cause the opposite eﬀect
and it is diﬃcult to draw conclusions based on this observation.
Given its inability to form the occluded conformation, it is
perhaps unclear how MpDHFR could faithfully follow the same
catalytic cycle as EcDHFR. The koff values for THF for the two
enzymes are similar, as are theKM values for NADPH, suggesting
that MpDHFR does not simply have reduced aﬃnity for both
forms of the cofactor or slower THF release to compensate for
the apparent increased NADP+ aﬃnity. MpDHFR also has a koff
for THF similar to that of LcDHFR (Table 3). Any eﬀect must
therefore be on NADP+ release itself. Although the aﬃnity of
Table 3. Dissociation Rate Constants (koff) for THF from the Various DHFRs, Measured Using the Competition Method with
Methotrexate as the Trapping Ligand, at 25 °C in MTEN Buﬀer (pH 6)
koff (s
−1)
complex EcDHFRa MpDHFR EcDHFR-S148P MpDHFR-P150S LcDHFRb
E·THF 0.97 ± 0.1 0.55 ± 0.1 0.5 ± 0.1 0.9 ± 0.2 0.5 ± 0.1
E·NADPH·THF 12.0 ± 1.0 19.1 ± 2.0 18.4 ± 0.8 17.3 ± 2.0 40.0 ± 8.0
E·NADP+·THF 2.4 ± 0.3 3.8 ± 1.0 2.6 ± 0.1 2.5 ± 1.0 1.7 ± 0.2
kcat (s
−1)c 9.5 ± 1.4 15.4 ± 0.3 2.4 ± 0.3 14.5 ± 0.4 31.0 ± 2.0
aSee ref 3. bSee ref 26 (pH 6.5). cMaximal value (MpDHFR and LcDHFR) or pH-independent value (all others).
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MpDHFR for NADP+ is greater than that of EcDHFR, it is not as
great as for EcDHFR-S148P. This suggests that MpDHFR has
additional features that reduce its aﬃnity for NADP+. A number
of residues in the NADP(H) binding site are diﬀerent between
the two enzymes, which may inﬂuence the relative aﬃnities of
NADP+ and NADPH. In addition, although two of the ﬁve steps
of the EcDHFR catalytic cycle are accompanied by transitions
between the closed and occluded conformations, the other three
are not.2 In these cases, progression through the catalytic cycle is
driven by local changes to residue dynamics that promote ligand
binding or release.4 It is possible that such local dynamics are
suﬃcient to control progression through all steps of the catalytic
cycle in MpDHFR.
An alternative possibility is that M. profunda has a lower
intracellular NADP+ concentration, as seen in vertebrates.
NADP+ represents only 1% of the NADPH concentration in
eukaryotic cells, but the two concentrations are equal in bacteria
such as E. coli; it has been suggested that the ﬁdelity of the order
of steps in the catalytic cycle acts to prevent product inhibition in
EcDHFR.2 A lower NADP+ concentration in M. profunda cells
would similarly eliminate the need for MpDHFR to adopt
strategies to avoid inhibition by this compound.
■ CONCLUSIONS
Here the role of the occluded conformation in DHFR catalysis
was investigated by a combination of site-directed mutagenesis,
steady state and pre-steady state kinetics, kinetic and equilibrium
binding measurements, and NMR spectroscopy. The ability to
adopt the occluded conformation does not aﬀect hydride transfer
proper. However, it is central to EcDHFR catalysis, because it
controls this enzyme’s aﬃnity for NADP+ and guides the enzyme
through the steps of the catalytic cycle in a strictly ordered
manner. Removal of the ability to form the occluded
conformation has a great impact on EcDHFR, resulting in a
change in the rate-limiting step and a decrease in the value of kcat.
In contrast, MpDHFR seems to follow a catalytic cycle similar to
that of EcDHFR, but it functions eﬃciently without the
involvement of an occluded conformation. Because many
DHFRs lack a hydrogen bond donor in the position
corresponding to Ser148 in EcDHFR, and because the occluded
conformation has been observed only in EcDHFR, the occluded
conformation is not a universal feature of bacterial DHFRs and
the E. coli enzymemay therefore not always be the best choice for
the study of general aspects of catalysis by dihydrofolate
reductase.
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